|Articles|September 1, 2011
- Pharmaceutical Executive-09-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - September 2011
From Many, One
Advertisement
Articles in this issue
almost 15 years ago
Pharm Exec's 10th Annual Industry Auditalmost 15 years ago
Pharma and Social Media: Ready to Make Nice?almost 15 years ago
The Power of Product Development Partnershipalmost 15 years ago
Front and Center in the Fight against TBalmost 15 years ago
How to Recruit 70,000 People in One Yearalmost 15 years ago
Innovating Around Innovationalmost 15 years ago
India: Good Endings, Good Beginnings!almost 15 years ago
Two Million Man Hoursalmost 15 years ago
Rebates and Reformalmost 15 years ago
Should the US Gamble with Risk Sharing?Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
2
GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc.
3
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering
4
Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion
5